Cart
sales@molnova.com
Integrin-IN-27
CAS No. 593274-97-6
Integrin-IN-27( MDK-4976 | Integrin Antagonist 27 | MDK4976 | MDK 4976 )
Catalog No. M15199 CAS No. 593274-97-6
A potent integrin αvβ3 antagonist with IC50 of 18 nM; could be conjugated to paclitaxel for selective delivery to alphavbeta3 positive metastatic cancer cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 312 | Get Quote |
|
| 50MG | 1341 | Get Quote |
|
| 100MG | 1791 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameIntegrin-IN-27
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent integrin αvβ3 antagonist with IC50 of 18 nM; could be conjugated to paclitaxel for selective delivery to alphavbeta3 positive metastatic cancer cells.
-
DescriptionA potent integrin αvβ3 antagonist with IC50 of 18 nM; could be conjugated to paclitaxel for selective delivery to alphavbeta3 positive metastatic cancer cells.
-
In Vitro——
-
In Vivo——
-
SynonymsMDK-4976 | Integrin Antagonist 27 | MDK4976 | MDK 4976
-
PathwayCell Cycle/DNA Damage
-
TargetIntegrin
-
RecptorIntegrin
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number593274-97-6
-
Formula Weight444.4394
-
Molecular FormulaC24H20N4O5
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(O)C1=CC=CC(N2C(/C=C(C(N3CC(NC4=CC=C(C)C=C4)=O)=O)/NC3=O)=CC=C2)=C1
-
Chemical NameBenzoic acid, 3-[2-[[1-[2-[(4-methylphenyl)amino]-2-oxoethyl]-2,5-dioxo-4-imidazolidinylidene]methyl]-1H-pyrrol-1-yl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Dayam R, et al. J Med Chem. 2006 Jul 27;49(15):4526-34.
molnova catalog
related products
-
Tirofiban hydrochlor...
A potent, selective inhibitor of the platelet fibrinogen receptor GPIIb/IIIa with IC50 of 9 nM.
-
Elarofiban
Elarofiban(RWJ-53308) is a novel and orally active GPIIb/IIIa antagonist.
-
Echistatin, α1 isofo...
Potent irreversible αVβ3 integrin antagonist (Ki = 0.27 nM). Disrupts attachment of osteoclasts to bone and inhibits bone reabsorption (IC50 = 0.1 nM). Prevents ADP-induced platelet aggregation via inhibition of glycoprotein IIb/IIIa (GpIIb/IIIa, αIIbβ3) receptors (IC50 = 30 nM) in vitro.
